Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial
Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
Institutions: University of Utah Health Care, Cedars-Sinai Medical Center, Cedars-Sinai Smidt Heart Institute, Emory University Hospital, Rush University Medical Center, University of Florida, University of Pittsburgh, Baylor University Medical Center, Aastrom Biosciences (United States), Brigham and Women's Hospital, University of California San Diego
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2321806604
